董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Paul Kusserow | 男 | Director | 59 | 119.59万美元 | 未持股 | 2021-03-11 |
| Mike Pykosz | 男 | Chairman, Chief Executive Officer and Director | 39 | 7354.87万美元 | 未持股 | 2021-03-11 |
| Geoff Price | 男 | Chief Operating Officer and Director | 39 | 5350.00万美元 | 未持股 | 2021-03-11 |
| Griffin Myers | 男 | Chief Medical Officer and Director | 39 | 4055.40万美元 | 未持股 | 2021-03-11 |
| Carl Daley | 男 | Director | 47 | 未披露 | 未持股 | 2021-03-11 |
| Robbert Vorhoff | 男 | Lead Director | 42 | 未披露 | 未持股 | 2021-03-11 |
| Srdjan Vukovic | 男 | Director | 38 | 未披露 | 未持股 | 2021-03-11 |
| Cheryl Dorsey | 女 | Director | 57 | 21.25万美元 | 未持股 | 2021-03-11 |
| Julie Klapstein | 女 | Director | 66 | 21.25万美元 | 未持股 | 2021-03-11 |
| Regina Benjamin | 女 | Director | 64 | 21.25万美元 | 未持股 | 2021-03-11 |
| Kim Keck | 女 | Director | 56 | 430.96万美元 | 未持股 | 2021-03-11 |
| Mohit Kaushal | 男 | Director | 42 | 234.78万美元 | 未持股 | 2021-03-11 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Mike Pykosz | 男 | Chairman, Chief Executive Officer and Director | 39 | 7354.87万美元 | 未持股 | 2021-03-11 |
| Timothy Cook | 男 | Chief Financial Officer | 39 | 未披露 | 未持股 | 2021-03-11 |
| Geoff Price | 男 | Chief Operating Officer and Director | 39 | 5350.00万美元 | 未持股 | 2021-03-11 |
| Griffin Myers | 男 | Chief Medical Officer and Director | 39 | 4055.40万美元 | 未持股 | 2021-03-11 |
| Brian Clem | -- | President | 38 | 未披露 | 未持股 | 2021-03-11 |
| Robert Guenthner | 男 | Chief Legal Officer | 49 | 未披露 | 未持股 | 2021-03-11 |
董事简历
中英对照 | 中文 | 英文- Paul Kusserow
-
Paul Kusserow，2014年10月起，他担任我公司董事会成员。2014年6月起，他担任综合临床护理公司Alignment Healthcare, Inc.的发展副主席和总裁。 加入Alignment Healthcare之前， 2008年1月至2013年7月，他担任一流健康与福利公司Humana Inc.的高级副总裁和首席战略创新与公司发展官，在该公司工作至2013年12月。他目前是New Century Health, Inc. 和AxelaCare Health Solutions, LLC.的董事会成员。他曾担任Availity Inc.和Healthsense, Inc.的董事会主席。 他在卫斯理大学（Wesleyan University）获得学士学位，在牛津大学（Oxford University）获得英语硕士学位。
Paul Kusserow has been a member of our Board since 2018. Mr. Kusserow serves as the Chairman, Chief Executive Officer and President at Amedisys, Inc., a publicly traded home healthcare and hospice company, since 2014. Prior to Amedisys, Mr. Kusserow was the Vice Chairman and President of Alignment Healthcare, Inc., an integrated care management and Medicare Advantage plan, in 2014 and was the Senior Vice President, Chief Strategy, Innovation and Corporate Development Officer at Humana Inc., a publicly traded health insurance company, from 2009 through 2013. Prior to that, Mr. Kusserow was a Managing Director and Chief Investment Officer at Ziegler HealthVest Fund, a healthcare investment company, from 2007 until 2009. He started his career at McKinsey and Company, Inc. Mr. Kusserow currently serves on the boards of Amedisys, Picwell, Inc. and Matrix Medical Network. Mr. Kusserow previously served on the boards of New Century Health, Inc., Connecture Inc. and AxelaCare Holdings, Inc., as well as Availity, Inc. and Healthsense, Inc., where he was Chairman of both boards. Mr. Kusserow received a M.A. with honors in English literature and language from the University of Oxford, where he was a Rhodes Scholar, and a B.A. in Religious Studies from Wesleyan University, Phi Beta Kappa, where he was an Olin Fellow and Brown Scholar. - Paul Kusserow，2014年10月起，他担任我公司董事会成员。2014年6月起，他担任综合临床护理公司Alignment Healthcare, Inc.的发展副主席和总裁。 加入Alignment Healthcare之前， 2008年1月至2013年7月，他担任一流健康与福利公司Humana Inc.的高级副总裁和首席战略创新与公司发展官，在该公司工作至2013年12月。他目前是New Century Health, Inc. 和AxelaCare Health Solutions, LLC.的董事会成员。他曾担任Availity Inc.和Healthsense, Inc.的董事会主席。 他在卫斯理大学（Wesleyan University）获得学士学位，在牛津大学（Oxford University）获得英语硕士学位。
- Paul Kusserow has been a member of our Board since 2018. Mr. Kusserow serves as the Chairman, Chief Executive Officer and President at Amedisys, Inc., a publicly traded home healthcare and hospice company, since 2014. Prior to Amedisys, Mr. Kusserow was the Vice Chairman and President of Alignment Healthcare, Inc., an integrated care management and Medicare Advantage plan, in 2014 and was the Senior Vice President, Chief Strategy, Innovation and Corporate Development Officer at Humana Inc., a publicly traded health insurance company, from 2009 through 2013. Prior to that, Mr. Kusserow was a Managing Director and Chief Investment Officer at Ziegler HealthVest Fund, a healthcare investment company, from 2007 until 2009. He started his career at McKinsey and Company, Inc. Mr. Kusserow currently serves on the boards of Amedisys, Picwell, Inc. and Matrix Medical Network. Mr. Kusserow previously served on the boards of New Century Health, Inc., Connecture Inc. and AxelaCare Holdings, Inc., as well as Availity, Inc. and Healthsense, Inc., where he was Chairman of both boards. Mr. Kusserow received a M.A. with honors in English literature and language from the University of Oxford, where he was a Rhodes Scholar, and a B.A. in Religious Studies from Wesleyan University, Phi Beta Kappa, where he was an Olin Fellow and Brown Scholar.
- Mike Pykosz
-
Mike Pykosz，自2012年共同创立Oak Street Health, Inc.以来，他一直担任Oak Street Health, Inc.的首席执行官兼董事会主席。在共同创立Oak Street Health之前，从2007年到2013年，他是Boston Consulting Group（一家咨询公司）的负责人。他持有Harvard Law School的法学博士学位和University of Notre Dame的生物化学学士学位。
Mike Pykosz has served as Oak Street Health, Inc. Chief Executive Officer and Chairman of Oak Street Health, Inc. Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Pykosz was a Principal at Boston Consulting Group, a consulting firm, from 2007 until 2013. Mr. Pykosz received a J.D. from Harvard Law School and a B.S. in Biochemistry from the University of Notre Dame. - Mike Pykosz，自2012年共同创立Oak Street Health, Inc.以来，他一直担任Oak Street Health, Inc.的首席执行官兼董事会主席。在共同创立Oak Street Health之前，从2007年到2013年，他是Boston Consulting Group（一家咨询公司）的负责人。他持有Harvard Law School的法学博士学位和University of Notre Dame的生物化学学士学位。
- Mike Pykosz has served as Oak Street Health, Inc. Chief Executive Officer and Chairman of Oak Street Health, Inc. Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Pykosz was a Principal at Boston Consulting Group, a consulting firm, from 2007 until 2013. Mr. Pykosz received a J.D. from Harvard Law School and a B.S. in Biochemistry from the University of Notre Dame.
- Geoff Price
-
Geoff Price自2012年共同创立公司以来，一直担任我们的首席运营官和董事会成员。在共同创立Oak Street Health之前，Price先生从2012年到2013年担任波士顿咨询集团（Boston Consulting Group）的项目负责人，从2010年到2012年担任顾问。Price先生在哈佛商学院（Harvard Business School）获得工商管理硕士学位，并在伊利诺伊大学（University of Illinois）获得工程学士学位。
Geoff Price has served as our Chief Operating Officer and a member of our Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Price was a Project Leader from 2012 until 2013 and a Consultant from 2010 to 2012 at Boston Consulting Group. Mr. Price received an M.B.A. from Harvard Business School and a B.S. in Engineering from the University of Illinois. - Geoff Price自2012年共同创立公司以来，一直担任我们的首席运营官和董事会成员。在共同创立Oak Street Health之前，Price先生从2012年到2013年担任波士顿咨询集团（Boston Consulting Group）的项目负责人，从2010年到2012年担任顾问。Price先生在哈佛商学院（Harvard Business School）获得工商管理硕士学位，并在伊利诺伊大学（University of Illinois）获得工程学士学位。
- Geoff Price has served as our Chief Operating Officer and a member of our Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Price was a Project Leader from 2012 until 2013 and a Consultant from 2010 to 2012 at Boston Consulting Group. Mr. Price received an M.B.A. from Harvard Business School and a B.S. in Engineering from the University of Illinois.
- Griffin Myers
-
Griffin Myers自2012年共同创立公司以来，一直担任我们的首席医疗官和董事会成员。Myers博士还是哈佛医学院（Harvard Medical School）的研究助理，自2018年以来，他一直担任西北大学范伯格医学院（Northwestern University&8217；s Feinberg School of Medicine）急诊医学系的兼职讲师，自2014年以来，他一直担任阿斯彭研究所（Aspen Institute）的健康创新研究员，他自2018年以来一直担任该职位。在此之前，Myers博士于2017年担任总统领导学者学者，并于2010年至2014年担任哈佛医学院临床研究员，并于2007年至2010年担任波士顿咨询集团项目负责人。Myers博士在芝加哥大学布斯商学院（University of Chicago-Booth School of Business）获得工商管理硕士学位，在芝加哥大学普利茨克医学院（University of Chicago Pritzker School of Medicine）获得医学博士学位，在戴维森学院（Davidson College）获得化学学士学位。
Griffin Myers has served as our Chief Medical Officer and a member of our Board since he co-founded the Company in 2012. Dr. Myers is also a Research Associate at Harvard Medical School, a position he has held since 2018 an Adjunct Instructor in the Department of Emergency Medicine at Northwestern University’s Feinberg School of Medicine, a position he has held since 2014 a Health Innovations Fellow at think tank The Aspen Institute, a position he has held since 2018. Prior to this, Dr. Myers was a Scholar in the Presidential Leadership Scholars in 2017 was a Clinical Fellow at Harvard Medical School from 2010 until 2014 and a Project Leader at Boston Consulting Group from 2007 until 2010. Dr. Myers received an M.B.A. from the University of Chicago-Booth School of Business, an M.D. from the University of Chicago Pritzker School of Medicine and a B.S. in Chemistry from Davidson College. - Griffin Myers自2012年共同创立公司以来，一直担任我们的首席医疗官和董事会成员。Myers博士还是哈佛医学院（Harvard Medical School）的研究助理，自2018年以来，他一直担任西北大学范伯格医学院（Northwestern University&8217；s Feinberg School of Medicine）急诊医学系的兼职讲师，自2014年以来，他一直担任阿斯彭研究所（Aspen Institute）的健康创新研究员，他自2018年以来一直担任该职位。在此之前，Myers博士于2017年担任总统领导学者学者，并于2010年至2014年担任哈佛医学院临床研究员，并于2007年至2010年担任波士顿咨询集团项目负责人。Myers博士在芝加哥大学布斯商学院（University of Chicago-Booth School of Business）获得工商管理硕士学位，在芝加哥大学普利茨克医学院（University of Chicago Pritzker School of Medicine）获得医学博士学位，在戴维森学院（Davidson College）获得化学学士学位。
- Griffin Myers has served as our Chief Medical Officer and a member of our Board since he co-founded the Company in 2012. Dr. Myers is also a Research Associate at Harvard Medical School, a position he has held since 2018 an Adjunct Instructor in the Department of Emergency Medicine at Northwestern University’s Feinberg School of Medicine, a position he has held since 2014 a Health Innovations Fellow at think tank The Aspen Institute, a position he has held since 2018. Prior to this, Dr. Myers was a Scholar in the Presidential Leadership Scholars in 2017 was a Clinical Fellow at Harvard Medical School from 2010 until 2014 and a Project Leader at Boston Consulting Group from 2007 until 2010. Dr. Myers received an M.B.A. from the University of Chicago-Booth School of Business, an M.D. from the University of Chicago Pritzker School of Medicine and a B.S. in Chemistry from Davidson College.
- Carl Daley
-
Carl Daley自2019年以来一直是我们的董事会成员。Daley先生是Humana零售战略和运营高级副总裁，自2020年以来一直担任该职位。在此之前，戴利先生于2017年至2020年担任高级副总裁兼保险首席财务官，于2014年至2017年担任企业副总裁兼首席审计官，并担任高级财务总监。产品，从2011年到2014年在Humana。在此之前，Daley先生从2000年开始在普华永道会计师事务所（Pricewaterhouse Coopers）担任多个职位，这是一家会计和咨询公司，最后的职位是高级会计师。从2010年到2011年担任审计经理。Daley先生在肯塔基大学（University of Kentucky）获得会计学硕士学位和B.S.。
Carl Daley has been a member of our Board since 2019. Mr. Daley is the SVP Retail Strategy and Operations at Humana, a healthcare company, a position he has held since 2020. Prior to this, Mr. Daley was the SVP and Insurance Chief Financial Officer from 2017 until 2020 the Enterprise VP and Chief Audit Officer from 2014 until 2017 and the Director of Finance, Sr. Products, from 2011 until 2014 at Humana. Prior to that, Mr. Daley held various positions at Pricewaterhouse Coopers, an accounting and consulting firm, since 2000 with his last position being a Sr. Manager, Audit from 2010 until 2011. Mr. Daley received a Master’s degree and a B.S. in Accounting from the University of Kentucky. - Carl Daley自2019年以来一直是我们的董事会成员。Daley先生是Humana零售战略和运营高级副总裁，自2020年以来一直担任该职位。在此之前，戴利先生于2017年至2020年担任高级副总裁兼保险首席财务官，于2014年至2017年担任企业副总裁兼首席审计官，并担任高级财务总监。产品，从2011年到2014年在Humana。在此之前，Daley先生从2000年开始在普华永道会计师事务所（Pricewaterhouse Coopers）担任多个职位，这是一家会计和咨询公司，最后的职位是高级会计师。从2010年到2011年担任审计经理。Daley先生在肯塔基大学（University of Kentucky）获得会计学硕士学位和B.S.。
- Carl Daley has been a member of our Board since 2019. Mr. Daley is the SVP Retail Strategy and Operations at Humana, a healthcare company, a position he has held since 2020. Prior to this, Mr. Daley was the SVP and Insurance Chief Financial Officer from 2017 until 2020 the Enterprise VP and Chief Audit Officer from 2014 until 2017 and the Director of Finance, Sr. Products, from 2011 until 2014 at Humana. Prior to that, Mr. Daley held various positions at Pricewaterhouse Coopers, an accounting and consulting firm, since 2000 with his last position being a Sr. Manager, Audit from 2010 until 2011. Mr. Daley received a Master’s degree and a B.S. in Accounting from the University of Kentucky.
- Robbert Vorhoff
-
Robbert Vorhoff自2014年以来一直担任我们的董事会成员。Vorhoff先生是纽约市General Atlantic公司的常务董事、管理委员会成员和梦百合全球主管。在2003年加入General Atlantic之前，Vorhoff先生曾在Greenhill&Co.工作，首先在并购和重组咨询集团，然后在私募股权集团Greenhill Capital Partners工作。Vorhoff先生目前是几家梦百合公司的董事会成员，其中包括Alternative Solutions Health Network、Doctor on Demand、Marathon Health、Oak Street Health和OneOncology。Vorhoff先生以前是Evicore梦百合、Align Networks（一个给妈妈的地方）和Medexpress的董事会成员。Vorhoff先生在弗吉尼亚大学（University of Virginia）麦金泰尔商学院（McIntire School of Commerce）获得商学学士学位，并专注于金融。
Robbert Vorhoff has been a member of our Board since 2015. Mr. Vorhoff is a Managing Director, Management Committee member and the Global Head of Healthcare at General Atlantic, an investment management firm, in New York City. Before joining General Atlantic in 2003 Mr. Vorhoff worked at Greenhill & Co., an investment bank, first in the mergers & acquisitions and restructuring advisory group, then in the private equity group, Greenhill Capital Partners. Mr. Vorhoff is currently a member of the board of several private healthcare companies, including Alignment Healthcare, Alternate Solutions Health Network, Doctor on Demand, Landmark Health, Marathon Health and OneOncology. Mr. Vorhoff previously was a member of the board of eviCore Healthcare, Align Networks and MedExpress. Mr. Vorhoff received a B.S. in Commerce with a concentration in Finance from the McIntire School of Commerce at the University of Virginia. - Robbert Vorhoff自2014年以来一直担任我们的董事会成员。Vorhoff先生是纽约市General Atlantic公司的常务董事、管理委员会成员和梦百合全球主管。在2003年加入General Atlantic之前，Vorhoff先生曾在Greenhill&Co.工作，首先在并购和重组咨询集团，然后在私募股权集团Greenhill Capital Partners工作。Vorhoff先生目前是几家梦百合公司的董事会成员，其中包括Alternative Solutions Health Network、Doctor on Demand、Marathon Health、Oak Street Health和OneOncology。Vorhoff先生以前是Evicore梦百合、Align Networks（一个给妈妈的地方）和Medexpress的董事会成员。Vorhoff先生在弗吉尼亚大学（University of Virginia）麦金泰尔商学院（McIntire School of Commerce）获得商学学士学位，并专注于金融。
- Robbert Vorhoff has been a member of our Board since 2015. Mr. Vorhoff is a Managing Director, Management Committee member and the Global Head of Healthcare at General Atlantic, an investment management firm, in New York City. Before joining General Atlantic in 2003 Mr. Vorhoff worked at Greenhill & Co., an investment bank, first in the mergers & acquisitions and restructuring advisory group, then in the private equity group, Greenhill Capital Partners. Mr. Vorhoff is currently a member of the board of several private healthcare companies, including Alignment Healthcare, Alternate Solutions Health Network, Doctor on Demand, Landmark Health, Marathon Health and OneOncology. Mr. Vorhoff previously was a member of the board of eviCore Healthcare, Align Networks and MedExpress. Mr. Vorhoff received a B.S. in Commerce with a concentration in Finance from the McIntire School of Commerce at the University of Virginia.
- Srdjan Vukovic
-
Srdjan Vukovic自2015年以来一直担任我们的董事会成员。Vukovic先生自2018年以来一直担任投资公司Newlight Partners LP的合伙人。在此之前，武科维奇先生于2006年至2018年在索罗斯基金管理公司（Soros Fund Management）工作，在此之前，是美林证券（Merrill Lynch）的分析师。Vukovic先生目前在几家私人公司的董事会任职，包括Zing Health Holdings，Inc.。Vukovic先生此前曾担任Zenium Data Centers的董事会成员，直到2017年该公司被Narragansett Bay Insurance Company收购，直到其被出售并成为一家上市公司的全资子公司，并担任多家私人保险公司的董事会成员。Vukovic先生在纽约大学（New York University）获得金融与精算学士学位。
Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and Jade Health, a service provider to behavioral health companies. Mr. Vukovic previoly served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University. - Srdjan Vukovic自2015年以来一直担任我们的董事会成员。Vukovic先生自2018年以来一直担任投资公司Newlight Partners LP的合伙人。在此之前，武科维奇先生于2006年至2018年在索罗斯基金管理公司（Soros Fund Management）工作，在此之前，是美林证券（Merrill Lynch）的分析师。Vukovic先生目前在几家私人公司的董事会任职，包括Zing Health Holdings，Inc.。Vukovic先生此前曾担任Zenium Data Centers的董事会成员，直到2017年该公司被Narragansett Bay Insurance Company收购，直到其被出售并成为一家上市公司的全资子公司，并担任多家私人保险公司的董事会成员。Vukovic先生在纽约大学（New York University）获得金融与精算学士学位。
- Srdjan Vukovic has served as a director of the Company since February 2025. Mr. Vukovic is a Partner at Sava Hill, a private investment firm. From 2018 to June 2025, he was a Partner at Newlight Partners LP, a private equity company. Prior to that, Mr. Vukovic worked at Soros Fund Management and was an analyst at Merrill Lynch. Mr. Vukovic currently serves on the board of Zing Health, a private health insurance company, and Jade Health, a service provider to behavioral health companies. Mr. Vukovic previoly served on the board of Oak Street Health, a publicly traded primary care provider, until it was acquired by CVS in 2023; Zenium Data Centers, until it was acquired by publicly traded CyrOne in 2017; Narragansett Bay Insurance Company, until it was sold and became a wholly owned subsidiary of the publicly traded Heritage Insurance Holdings, Inc.; and several private insurance companies. Mr. Vukovic received a B.S. in Finance and Actuarial Science from New York University.
- Cheryl Dorsey
-
Cheryl Dorsey预计将在本次发行完成前加入我们的董事会。Dorsey女士自2002年以来一直担任Echoing Green（一家全球社会风险基金）的总裁。在此之前，Dorsey女士从1997年到1998年担任白宫研究员，担任美国劳工部长特别助理，就医疗保健和其他问题为克林顿政府提供建议。她后来被任命为美国劳工部妇女局局长的特别助理。她最近于2009年至2017年担任白宫研究金总统委员会副主席，此前曾担任奥巴马总统过渡时期技术，创新和政府改革政策工作组创新和民间社会分组的团队成员。2009年，她被《美国新闻与世界报道》（U.S.News&World Report）和哈佛大学（Harvard University）JohnF.Kennedy政府学院公共领导力中心评为美国最佳领导人之一。2010年和2011年，她被评为《纽约时报》“权力与影响力50强”之一。Dorsey女士目前在Northeast Bancorp和Bridgespan Group的董事会任职。她也是Accelerator for America的顾问委员会成员。
Cheryl Dorsey has been a member of our Board since 2020. Ms. Dorsey has been the president of Echoing Green, a global social venture fund, since 2002. Prior to this, Ms. Dorsey served as a White House Fellow from 1997 to 1998 serving as Special Assistant to the U.S. Secretary of Labor, advising the Clinton Administration on health care and other issues. She was later named Special Assistant to the Director of the Women’s Bureau of the U.S. Labor Department. She most recently served as Vice-Chair of the President’s Commission on White House Fellowships from 2009-2017 after serving as a team member of the Innovation and Civil Society subgroup of the Obama Presidential Transition’s Technology, Innovation, and Government Reform Policy Working Group. She was named one of “America’s Best Leaders” in 2009 by U.S. News & World Report and the Center for Public Leadership at the John F. Kennedy School of Government at Harvard University. For 2010 and 2011 she was named as one of The Nonprofit Times’ “Power and Influence Top 50.” Ms. Dorsey currently serves on the board of Northeast Bancorp and The Bridgespan Group. She is also an Advisory Council member of Accelerator for America. - Cheryl Dorsey预计将在本次发行完成前加入我们的董事会。Dorsey女士自2002年以来一直担任Echoing Green（一家全球社会风险基金）的总裁。在此之前，Dorsey女士从1997年到1998年担任白宫研究员，担任美国劳工部长特别助理，就医疗保健和其他问题为克林顿政府提供建议。她后来被任命为美国劳工部妇女局局长的特别助理。她最近于2009年至2017年担任白宫研究金总统委员会副主席，此前曾担任奥巴马总统过渡时期技术，创新和政府改革政策工作组创新和民间社会分组的团队成员。2009年，她被《美国新闻与世界报道》（U.S.News&World Report）和哈佛大学（Harvard University）JohnF.Kennedy政府学院公共领导力中心评为美国最佳领导人之一。2010年和2011年，她被评为《纽约时报》“权力与影响力50强”之一。Dorsey女士目前在Northeast Bancorp和Bridgespan Group的董事会任职。她也是Accelerator for America的顾问委员会成员。
- Cheryl Dorsey has been a member of our Board since 2020. Ms. Dorsey has been the president of Echoing Green, a global social venture fund, since 2002. Prior to this, Ms. Dorsey served as a White House Fellow from 1997 to 1998 serving as Special Assistant to the U.S. Secretary of Labor, advising the Clinton Administration on health care and other issues. She was later named Special Assistant to the Director of the Women’s Bureau of the U.S. Labor Department. She most recently served as Vice-Chair of the President’s Commission on White House Fellowships from 2009-2017 after serving as a team member of the Innovation and Civil Society subgroup of the Obama Presidential Transition’s Technology, Innovation, and Government Reform Policy Working Group. She was named one of “America’s Best Leaders” in 2009 by U.S. News & World Report and the Center for Public Leadership at the John F. Kennedy School of Government at Harvard University. For 2010 and 2011 she was named as one of The Nonprofit Times’ “Power and Influence Top 50.” Ms. Dorsey currently serves on the board of Northeast Bancorp and The Bridgespan Group. She is also an Advisory Council member of Accelerator for America.
- Julie Klapstein
-
Julie Klapstein预计将在本次发行完成前加入我们的董事会。Klapstein女士是Availity，LLC的创始首席执行官，该公司是一家优化梦百合利益相关者之间关键业务和临床信息自动传递的健康信息网络。Klapstein女士从2001年到2011年担任Availity&8217；的首席执行官兼董事会成员。她于2017年2月至2017年6月担任私营公司America，Inc.医疗报销的临时首席执行官。Klapstein女士目前任职于Amedisys的董事会，在那里她任职于治理和质量委员会，在那里她担任薪酬委员会主席，以及NextGen梦百合的董事会，在那里她担任薪酬委员会主席。她目前也任职于两家私人公司的董事会。Klapstein之前从2012年1月到2014年9月担任Annie&8217；s Homedrown/Annies，Inc.两家上市公司董事，2011年4月到2014年11月担任Standard Register Inc.治理、薪酬和审计委员会成员。她也一直担任多个私人公司的董事。Klapstein女士在俄勒冈州波特兰的波特兰州立大学（Portland State University）获得学士学位。
Julie Klapstein,has served as a member of board of directors since June 2024. Ms. Klapstein founded and served as the Chief Executive Officer of Availity, LLC, a healthcare information technology company, from May 2001 to March 2012. She also previously served as interim Chief Executive Officer of Medical Reimbursements of America, Inc., a provider of specialty reimbursement services, from February 2017 to June 2017. Ms. Klapstein has served on the boards of directors of Amedisys, Inc., a publicly held home healthcare provider, since April 2016, Claritev Corporation (f/k/a MultiPlan Corporation), a publicly held provider of business analytics and health cost management solutions, since November 2020, HealthCare Information Management, Inc., a robotic process automation company, since May 2024, Aptarro, Inc. (f/k/a Alpha II, LLC), a provider of revenue cycle management solutions for healthcare providers, since June 2024, and UnisLink Inc., a medical billing system vendor for healthcare providers, since July 2024, and also currently serves as an advisor to venture capital and private equity firms such as Andreessen Horowitz, GrowthCurve Capital, and Riverside Partners. She previously served on the boards of directors of numerous publicly held companies, including NextGen Healthcare, Inc., a healthcare technology company acquired by Thoma Bravo, from August 2017 to November 2023, and Oak Street Health, Inc., a primary care provider acquired by CVS Health, from August 2020 to May 2023. Ms. Klapstein holds a B.S. in Business Administration from Portland State University. - Julie Klapstein预计将在本次发行完成前加入我们的董事会。Klapstein女士是Availity，LLC的创始首席执行官，该公司是一家优化梦百合利益相关者之间关键业务和临床信息自动传递的健康信息网络。Klapstein女士从2001年到2011年担任Availity&8217；的首席执行官兼董事会成员。她于2017年2月至2017年6月担任私营公司America，Inc.医疗报销的临时首席执行官。Klapstein女士目前任职于Amedisys的董事会，在那里她任职于治理和质量委员会，在那里她担任薪酬委员会主席，以及NextGen梦百合的董事会，在那里她担任薪酬委员会主席。她目前也任职于两家私人公司的董事会。Klapstein之前从2012年1月到2014年9月担任Annie&8217；s Homedrown/Annies，Inc.两家上市公司董事，2011年4月到2014年11月担任Standard Register Inc.治理、薪酬和审计委员会成员。她也一直担任多个私人公司的董事。Klapstein女士在俄勒冈州波特兰的波特兰州立大学（Portland State University）获得学士学位。
- Julie Klapstein,has served as a member of board of directors since June 2024. Ms. Klapstein founded and served as the Chief Executive Officer of Availity, LLC, a healthcare information technology company, from May 2001 to March 2012. She also previously served as interim Chief Executive Officer of Medical Reimbursements of America, Inc., a provider of specialty reimbursement services, from February 2017 to June 2017. Ms. Klapstein has served on the boards of directors of Amedisys, Inc., a publicly held home healthcare provider, since April 2016, Claritev Corporation (f/k/a MultiPlan Corporation), a publicly held provider of business analytics and health cost management solutions, since November 2020, HealthCare Information Management, Inc., a robotic process automation company, since May 2024, Aptarro, Inc. (f/k/a Alpha II, LLC), a provider of revenue cycle management solutions for healthcare providers, since June 2024, and UnisLink Inc., a medical billing system vendor for healthcare providers, since July 2024, and also currently serves as an advisor to venture capital and private equity firms such as Andreessen Horowitz, GrowthCurve Capital, and Riverside Partners. She previously served on the boards of directors of numerous publicly held companies, including NextGen Healthcare, Inc., a healthcare technology company acquired by Thoma Bravo, from August 2017 to November 2023, and Oak Street Health, Inc., a primary care provider acquired by CVS Health, from August 2020 to May 2023. Ms. Klapstein holds a B.S. in Business Administration from Portland State University.
- Regina Benjamin
-
Regina Benjamin，现任BayouClinic，Inc.的创始人兼首席执行官。Benjamin于2009年7月被美国总统奥巴马任命为第18任美国外科医生，并于2009年11月至2013年8月担任该职务。此外，Benjamin拥有大约30年的家庭医生执业经验。Benjamin博士自1990年起担任BayouClinic/海湾国家卫生政策中心的创始人和首席执行官，并自2013年9月起担任路易斯安那州泽维尔大学NOLA.com/Times Picayune公共Health Sciences捐赠主席。Benjamin博士曾分别担任公立医疗保健服务公司Oak Street Health, Inc.的董事会成员，直至其被CVS收购，自2020年10月至2023年4月，Ascension Health Alliance，一家私营医疗保健公司，自2014年6月至2023年6月，公立医疗器械公司Alere Inc.，自2013年12月至2015年7月，提供专科药房服务的公众公司Diplomat Pharmacy,Inc.，在被OptimRx收购之前，自2013年4月至2015年，公立医疗产品和技术公司ConvaTec Group PLC，自2017年8月至2022年5月，并于2014年6月至2019年6月担任March of Dimes董事会成员。Benjamin博士目前担任上市技术公司计算机程序和系统，Inc.（现为TruBridge，Inc.）的董事会成员，自2017年11月起担任该公司的董事，自2015年6月起担任Kaiser Foundation Hospitals and Health Plan的董事，并担任为早产儿加工母乳的私营公司Prolacta的董事。本杰明博士还自2020年5月起担任私人增长资本公司HealthQuest Capital的顾问委员会成员，并自2019年起担任美国心脏协会成员。她拥有路易斯安那州泽维尔大学化学学士学位、阿拉巴马大学伯明翰分校医学博士学位和杜兰大学工商管理硕士学位。
Regina Benjamin,is currently the founder and chief executive officer of, and is a practicing physician at, BayouClinic, Inc., since January 1990. Dr. Benjamin was appointed as the 18th United States Surgeon General by President Barack Obama in July 2009 and served in that role from November 2009 to August 2013. In addition, Dr. Benjamin has approximately 30 years of experience as a practicing family physician. Dr. Benjamin has served as the founder and chief executive officer of the BayouClinic/Gulf States Health Policy Center since 1990, and as the NOLA.com/Times Picayune Endowed Chair in Public Health Sciences at Xavier University of Louisiana since September 2013. Dr. Benjamin served as a member of the boards of directors of each of the Oak Street Health, Inc., a public healthcare services company, until its acquisition by CVS, from October 2020 to April 2023, Ascension Health Alliance, a private healthcare company, from June 2014 to June 2023, Alere Inc., a public medical device company, from December 2013 to July 2015, Diplomat Pharmacy, Inc., a public company providing specialty pharmacy services, prior to its acquisition by OptimRx, from April 2013 to 2015, ConvaTec Group plc, a public medical products and technologies company, from August 2017 to May 2022 and as a member of the March of Dimes Board of Trustees from June 2014 to June 2019. Dr. Benjamin currently serves on the boards of Computer Programs and Systems, Inc. (now TruBridge, Inc.), a public technology company, since November 2017, Kaiser Foundation Hospitals and Health Plan since June 2015, and Prolacta, a private company that processes breast milk for premature infants. Dr. Benjamin also serves on the advisory board of HealthQuest Capital, a private growth capital firm, since May 2020, and the American Heart Association since 2019. She holds a B.S. in Chemistry from Xavier University of Louisiana, an M.D. from the University of Alabama at Birmingham, and an M.B.A from Tulane University. - Regina Benjamin，现任BayouClinic，Inc.的创始人兼首席执行官。Benjamin于2009年7月被美国总统奥巴马任命为第18任美国外科医生，并于2009年11月至2013年8月担任该职务。此外，Benjamin拥有大约30年的家庭医生执业经验。Benjamin博士自1990年起担任BayouClinic/海湾国家卫生政策中心的创始人和首席执行官，并自2013年9月起担任路易斯安那州泽维尔大学NOLA.com/Times Picayune公共Health Sciences捐赠主席。Benjamin博士曾分别担任公立医疗保健服务公司Oak Street Health, Inc.的董事会成员，直至其被CVS收购，自2020年10月至2023年4月，Ascension Health Alliance，一家私营医疗保健公司，自2014年6月至2023年6月，公立医疗器械公司Alere Inc.，自2013年12月至2015年7月，提供专科药房服务的公众公司Diplomat Pharmacy,Inc.，在被OptimRx收购之前，自2013年4月至2015年，公立医疗产品和技术公司ConvaTec Group PLC，自2017年8月至2022年5月，并于2014年6月至2019年6月担任March of Dimes董事会成员。Benjamin博士目前担任上市技术公司计算机程序和系统，Inc.（现为TruBridge，Inc.）的董事会成员，自2017年11月起担任该公司的董事，自2015年6月起担任Kaiser Foundation Hospitals and Health Plan的董事，并担任为早产儿加工母乳的私营公司Prolacta的董事。本杰明博士还自2020年5月起担任私人增长资本公司HealthQuest Capital的顾问委员会成员，并自2019年起担任美国心脏协会成员。她拥有路易斯安那州泽维尔大学化学学士学位、阿拉巴马大学伯明翰分校医学博士学位和杜兰大学工商管理硕士学位。
- Regina Benjamin,is currently the founder and chief executive officer of, and is a practicing physician at, BayouClinic, Inc., since January 1990. Dr. Benjamin was appointed as the 18th United States Surgeon General by President Barack Obama in July 2009 and served in that role from November 2009 to August 2013. In addition, Dr. Benjamin has approximately 30 years of experience as a practicing family physician. Dr. Benjamin has served as the founder and chief executive officer of the BayouClinic/Gulf States Health Policy Center since 1990, and as the NOLA.com/Times Picayune Endowed Chair in Public Health Sciences at Xavier University of Louisiana since September 2013. Dr. Benjamin served as a member of the boards of directors of each of the Oak Street Health, Inc., a public healthcare services company, until its acquisition by CVS, from October 2020 to April 2023, Ascension Health Alliance, a private healthcare company, from June 2014 to June 2023, Alere Inc., a public medical device company, from December 2013 to July 2015, Diplomat Pharmacy, Inc., a public company providing specialty pharmacy services, prior to its acquisition by OptimRx, from April 2013 to 2015, ConvaTec Group plc, a public medical products and technologies company, from August 2017 to May 2022 and as a member of the March of Dimes Board of Trustees from June 2014 to June 2019. Dr. Benjamin currently serves on the boards of Computer Programs and Systems, Inc. (now TruBridge, Inc.), a public technology company, since November 2017, Kaiser Foundation Hospitals and Health Plan since June 2015, and Prolacta, a private company that processes breast milk for premature infants. Dr. Benjamin also serves on the advisory board of HealthQuest Capital, a private growth capital firm, since May 2020, and the American Heart Association since 2019. She holds a B.S. in Chemistry from Xavier University of Louisiana, an M.D. from the University of Alabama at Birmingham, and an M.B.A from Tulane University.
- Kim Keck
-
Kim Keck自2021年1月起担任Blue Cross Blue Shield Association的总裁兼首席执行官。从2016年6月至2020年12月，Keck女士曾担任罗德岛Blue Cross Blue Shield的总裁兼首席执行官。此前，Keck女士于2001年至2016年在Aetna担任多个领导职务，包括2010年至2016年担任高级副总裁。Keck女士是Oak Street Health和Blue Cross Blue Shield Association的董事会成员。她在波士顿学院获得数学学士学位，在康涅狄格大学获得金融工商管理硕士学位，是一名特许金融分析师。
Kim Keck has served as the President and CEO of Blue Cross Blue Shield Association since January 2021 . From June 2016 to December 2020 Ms. Keck previously served as the President and Chief Executive Officer of Blue Cross Blue Shield of Rhode Island. Previously, Ms. Keck held several leadership roles at Aetna from 2001 to 2016 including Senior Vice President from 2010 to 2016. Ms. Keck serves on the Board of Directors of Oak Street Health and the Blue Cross Blue Shield Association. She received a B.A. in Mathematics from Boston College and an MBA in Finance from the University of Connecticut and is a Chartered Financial Analyst. - Kim Keck自2021年1月起担任Blue Cross Blue Shield Association的总裁兼首席执行官。从2016年6月至2020年12月，Keck女士曾担任罗德岛Blue Cross Blue Shield的总裁兼首席执行官。此前，Keck女士于2001年至2016年在Aetna担任多个领导职务，包括2010年至2016年担任高级副总裁。Keck女士是Oak Street Health和Blue Cross Blue Shield Association的董事会成员。她在波士顿学院获得数学学士学位，在康涅狄格大学获得金融工商管理硕士学位，是一名特许金融分析师。
- Kim Keck has served as the President and CEO of Blue Cross Blue Shield Association since January 2021 . From June 2016 to December 2020 Ms. Keck previously served as the President and Chief Executive Officer of Blue Cross Blue Shield of Rhode Island. Previously, Ms. Keck held several leadership roles at Aetna from 2001 to 2016 including Senior Vice President from 2010 to 2016. Ms. Keck serves on the Board of Directors of Oak Street Health and the Blue Cross Blue Shield Association. She received a B.A. in Mathematics from Boston College and an MBA in Finance from the University of Connecticut and is a Chartered Financial Analyst.
- Mohit Kaushal
-
Mohit Kaushal自2020年3月10日起担任董事。他在投资、临床医学和公共政策领域有着广泛的职业生涯。Kaushal博士自2015年以来一直担任General Atlantic的特别顾问。他曾担任Aberdare Ventures公司的合伙人（从2013年到2014年）。在奥巴马政府期间，他是白宫卫生IT工作组的成员，该工作组是一个跨机构团队，负责实施ACA的技术方面，并就医疗保险人口的技术应用和支付改革向国会作证。他还在联邦通信委员会建立并领导了第一个专门的医疗保健团队，在该委员会，他的团队发起了与美国食品和药物管理局的合作，以简化融合电信的监管，数据分析和医疗设备导致FDA发布移动医疗应用指南。此外，他的团队对农村医疗保健基金进行了改革，建立了医疗保健连接基金，该基金使供资机制与更广泛的医疗保健支付政策和技术改革保持一致。Kaushal博士是众多转型医疗保健公司的首席投资者，董事会成员或顾问。Kaushal博士是一名急诊室医生，拥有斯坦福大学的工商管理硕士学位和伦敦帝国理工学院的医学博士学位。他是斯坦福大学的兼职教授，在新成立的生物医学数据科学系和医学院的临床卓越研究中心担任联合职位。
Mohit Kaushal has served as a director as of March 10 2020. He has had an extensive career within investing, clinical medicine and public policy. Dr. Kaushal has served as a special advisor to General Atlantic since 2015. He was a partner in Aberdare Ventures from 2013 to 2014. During his time in the Obama administration, he was a member of the White House Health IT task force; a cross agency team implementing the technology aspects of the ACA and testified to Congress on the application of technology and payment reform to the Medicare population. He also built and led the first dedicated healthcare team at the Federal Communications Commission, where his team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA. In addition, his team reformed the Rural Healthcare fund to create the Healthcare Connect Fund, which aligned the funding mechanism with wider healthcare payment policy and technology reform. Dr. Kaushal is a lead investor, board member or advisor to numerous transformational healthcare companies. Dr. Kaushal is an emergency room physician, holds an MBA from Stanford and an MD with distinction from Imperial College of Science, Technology and Medicine, London. He is an Adjunct Professor at Stanford University with a joint position within the newly created Biomedical Data Science Department and the medical school's Clinical Excellence Research Center. - Mohit Kaushal自2020年3月10日起担任董事。他在投资、临床医学和公共政策领域有着广泛的职业生涯。Kaushal博士自2015年以来一直担任General Atlantic的特别顾问。他曾担任Aberdare Ventures公司的合伙人（从2013年到2014年）。在奥巴马政府期间，他是白宫卫生IT工作组的成员，该工作组是一个跨机构团队，负责实施ACA的技术方面，并就医疗保险人口的技术应用和支付改革向国会作证。他还在联邦通信委员会建立并领导了第一个专门的医疗保健团队，在该委员会，他的团队发起了与美国食品和药物管理局的合作，以简化融合电信的监管，数据分析和医疗设备导致FDA发布移动医疗应用指南。此外，他的团队对农村医疗保健基金进行了改革，建立了医疗保健连接基金，该基金使供资机制与更广泛的医疗保健支付政策和技术改革保持一致。Kaushal博士是众多转型医疗保健公司的首席投资者，董事会成员或顾问。Kaushal博士是一名急诊室医生，拥有斯坦福大学的工商管理硕士学位和伦敦帝国理工学院的医学博士学位。他是斯坦福大学的兼职教授，在新成立的生物医学数据科学系和医学院的临床卓越研究中心担任联合职位。
- Mohit Kaushal has served as a director as of March 10 2020. He has had an extensive career within investing, clinical medicine and public policy. Dr. Kaushal has served as a special advisor to General Atlantic since 2015. He was a partner in Aberdare Ventures from 2013 to 2014. During his time in the Obama administration, he was a member of the White House Health IT task force; a cross agency team implementing the technology aspects of the ACA and testified to Congress on the application of technology and payment reform to the Medicare population. He also built and led the first dedicated healthcare team at the Federal Communications Commission, where his team initiated collaboration with the Food and Drug Administration for the regulatory streamlining of converged telecommunications, data analytics and medical devices leading to the release of the mobile medical applications guidance by the FDA. In addition, his team reformed the Rural Healthcare fund to create the Healthcare Connect Fund, which aligned the funding mechanism with wider healthcare payment policy and technology reform. Dr. Kaushal is a lead investor, board member or advisor to numerous transformational healthcare companies. Dr. Kaushal is an emergency room physician, holds an MBA from Stanford and an MD with distinction from Imperial College of Science, Technology and Medicine, London. He is an Adjunct Professor at Stanford University with a joint position within the newly created Biomedical Data Science Department and the medical school's Clinical Excellence Research Center.
高管简历
中英对照 | 中文 | 英文- Mike Pykosz
Mike Pykosz，自2012年共同创立Oak Street Health, Inc.以来，他一直担任Oak Street Health, Inc.的首席执行官兼董事会主席。在共同创立Oak Street Health之前，从2007年到2013年，他是Boston Consulting Group（一家咨询公司）的负责人。他持有Harvard Law School的法学博士学位和University of Notre Dame的生物化学学士学位。
Mike Pykosz has served as Oak Street Health, Inc. Chief Executive Officer and Chairman of Oak Street Health, Inc. Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Pykosz was a Principal at Boston Consulting Group, a consulting firm, from 2007 until 2013. Mr. Pykosz received a J.D. from Harvard Law School and a B.S. in Biochemistry from the University of Notre Dame.- Mike Pykosz，自2012年共同创立Oak Street Health, Inc.以来，他一直担任Oak Street Health, Inc.的首席执行官兼董事会主席。在共同创立Oak Street Health之前，从2007年到2013年，他是Boston Consulting Group（一家咨询公司）的负责人。他持有Harvard Law School的法学博士学位和University of Notre Dame的生物化学学士学位。
- Mike Pykosz has served as Oak Street Health, Inc. Chief Executive Officer and Chairman of Oak Street Health, Inc. Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Pykosz was a Principal at Boston Consulting Group, a consulting firm, from 2007 until 2013. Mr. Pykosz received a J.D. from Harvard Law School and a B.S. in Biochemistry from the University of Notre Dame.
- Timothy Cook
Timothy Cook自2019年以来一直担任我们的首席财务官。在Oak Street Health任职之前，库克曾于2016年至2019年担任医疗福利管理公司Evicore梦百合的首席财务官，该公司于2017年被Express Scripts Holdings收购。在此之前，库克曾于2010年至2016年担任通用大西洋公司（General Atlantic）Vice President-梦百合，并在此之前担任过其他财务咨询职务。Cook先生在哥伦比亚商学院（Columbia Business School）获得工商管理硕士学位，在里士满大学（University of Richmond）获得工商管理、金融/经济学学士学位。
Timothy Cook has served as our Chief Financial Officer since 2019. Prior to his position at Oak Street Health, Mr. Cook was the Chief Financial Officer of eviCore healthcare, a medical benefit management company that was acquired by Express Scripts Holdings in 2017 from 2016 until 2019. Prior to that, Mr. Cook was a Vice President-Healthcare at General Atlantic from 2010 to 2016 and he served in other financial consulting roles prior to that. Mr. Cook received an M.B.A. from Columbia Business School and a B.S. in Business Administration, Finance/ Economics from the University of Richmond.- Timothy Cook自2019年以来一直担任我们的首席财务官。在Oak Street Health任职之前，库克曾于2016年至2019年担任医疗福利管理公司Evicore梦百合的首席财务官，该公司于2017年被Express Scripts Holdings收购。在此之前，库克曾于2010年至2016年担任通用大西洋公司（General Atlantic）Vice President-梦百合，并在此之前担任过其他财务咨询职务。Cook先生在哥伦比亚商学院（Columbia Business School）获得工商管理硕士学位，在里士满大学（University of Richmond）获得工商管理、金融/经济学学士学位。
- Timothy Cook has served as our Chief Financial Officer since 2019. Prior to his position at Oak Street Health, Mr. Cook was the Chief Financial Officer of eviCore healthcare, a medical benefit management company that was acquired by Express Scripts Holdings in 2017 from 2016 until 2019. Prior to that, Mr. Cook was a Vice President-Healthcare at General Atlantic from 2010 to 2016 and he served in other financial consulting roles prior to that. Mr. Cook received an M.B.A. from Columbia Business School and a B.S. in Business Administration, Finance/ Economics from the University of Richmond.
- Geoff Price
Geoff Price自2012年共同创立公司以来，一直担任我们的首席运营官和董事会成员。在共同创立Oak Street Health之前，Price先生从2012年到2013年担任波士顿咨询集团（Boston Consulting Group）的项目负责人，从2010年到2012年担任顾问。Price先生在哈佛商学院（Harvard Business School）获得工商管理硕士学位，并在伊利诺伊大学（University of Illinois）获得工程学士学位。
Geoff Price has served as our Chief Operating Officer and a member of our Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Price was a Project Leader from 2012 until 2013 and a Consultant from 2010 to 2012 at Boston Consulting Group. Mr. Price received an M.B.A. from Harvard Business School and a B.S. in Engineering from the University of Illinois.- Geoff Price自2012年共同创立公司以来，一直担任我们的首席运营官和董事会成员。在共同创立Oak Street Health之前，Price先生从2012年到2013年担任波士顿咨询集团（Boston Consulting Group）的项目负责人，从2010年到2012年担任顾问。Price先生在哈佛商学院（Harvard Business School）获得工商管理硕士学位，并在伊利诺伊大学（University of Illinois）获得工程学士学位。
- Geoff Price has served as our Chief Operating Officer and a member of our Board since he co-founded the Company in 2012. Prior to co-founding Oak Street Health, Mr. Price was a Project Leader from 2012 until 2013 and a Consultant from 2010 to 2012 at Boston Consulting Group. Mr. Price received an M.B.A. from Harvard Business School and a B.S. in Engineering from the University of Illinois.
- Griffin Myers
Griffin Myers自2012年共同创立公司以来，一直担任我们的首席医疗官和董事会成员。Myers博士还是哈佛医学院（Harvard Medical School）的研究助理，自2018年以来，他一直担任西北大学范伯格医学院（Northwestern University&8217；s Feinberg School of Medicine）急诊医学系的兼职讲师，自2014年以来，他一直担任阿斯彭研究所（Aspen Institute）的健康创新研究员，他自2018年以来一直担任该职位。在此之前，Myers博士于2017年担任总统领导学者学者，并于2010年至2014年担任哈佛医学院临床研究员，并于2007年至2010年担任波士顿咨询集团项目负责人。Myers博士在芝加哥大学布斯商学院（University of Chicago-Booth School of Business）获得工商管理硕士学位，在芝加哥大学普利茨克医学院（University of Chicago Pritzker School of Medicine）获得医学博士学位，在戴维森学院（Davidson College）获得化学学士学位。
Griffin Myers has served as our Chief Medical Officer and a member of our Board since he co-founded the Company in 2012. Dr. Myers is also a Research Associate at Harvard Medical School, a position he has held since 2018 an Adjunct Instructor in the Department of Emergency Medicine at Northwestern University’s Feinberg School of Medicine, a position he has held since 2014 a Health Innovations Fellow at think tank The Aspen Institute, a position he has held since 2018. Prior to this, Dr. Myers was a Scholar in the Presidential Leadership Scholars in 2017 was a Clinical Fellow at Harvard Medical School from 2010 until 2014 and a Project Leader at Boston Consulting Group from 2007 until 2010. Dr. Myers received an M.B.A. from the University of Chicago-Booth School of Business, an M.D. from the University of Chicago Pritzker School of Medicine and a B.S. in Chemistry from Davidson College.- Griffin Myers自2012年共同创立公司以来，一直担任我们的首席医疗官和董事会成员。Myers博士还是哈佛医学院（Harvard Medical School）的研究助理，自2018年以来，他一直担任西北大学范伯格医学院（Northwestern University&8217；s Feinberg School of Medicine）急诊医学系的兼职讲师，自2014年以来，他一直担任阿斯彭研究所（Aspen Institute）的健康创新研究员，他自2018年以来一直担任该职位。在此之前，Myers博士于2017年担任总统领导学者学者，并于2010年至2014年担任哈佛医学院临床研究员，并于2007年至2010年担任波士顿咨询集团项目负责人。Myers博士在芝加哥大学布斯商学院（University of Chicago-Booth School of Business）获得工商管理硕士学位，在芝加哥大学普利茨克医学院（University of Chicago Pritzker School of Medicine）获得医学博士学位，在戴维森学院（Davidson College）获得化学学士学位。
- Griffin Myers has served as our Chief Medical Officer and a member of our Board since he co-founded the Company in 2012. Dr. Myers is also a Research Associate at Harvard Medical School, a position he has held since 2018 an Adjunct Instructor in the Department of Emergency Medicine at Northwestern University’s Feinberg School of Medicine, a position he has held since 2014 a Health Innovations Fellow at think tank The Aspen Institute, a position he has held since 2018. Prior to this, Dr. Myers was a Scholar in the Presidential Leadership Scholars in 2017 was a Clinical Fellow at Harvard Medical School from 2010 until 2014 and a Project Leader at Boston Consulting Group from 2007 until 2010. Dr. Myers received an M.B.A. from the University of Chicago-Booth School of Business, an M.D. from the University of Chicago Pritzker School of Medicine and a B.S. in Chemistry from Davidson College.
- Brian Clem
Brian Clem自2019年起担任Oak Street Health总裁，并于2015年加入该公司，担任部门Vice President。在加入Oak Street Health之前，布莱恩于2013年至2015年在印第安纳大学健康计划（英语:IU Health Plans）领导Medicare Advantage业务，该计划是印第安纳大学健康系统的一部分。2013年之前，Brian从2004年开始在Eli Lilly&Co.（一家全球制药公司）担任领导职位。Brian在Stanford University&8217；s Graduate School of Business获得工商管理硕士学位，在Wabash College获得经济学学士学位。
Brian Clem has served as President of Oak Street Health since 2019 having joined the company in 2015 as a Divisional Vice President. Prior to joining Oak Street Health, Brian led the Medicare Advantage business from 2013 until 2015 at IU Health Plans, which is part of the Indiana University Health system. Prior to 2013 Brian served in leadership roles at Eli Lilly & Co., a global pharmaceutical company, beginning in 2004. Brian received an M.B.A. from Stanford University’s Graduate School of Business and a B.A. in Economics from Wabash College.- Brian Clem自2019年起担任Oak Street Health总裁，并于2015年加入该公司，担任部门Vice President。在加入Oak Street Health之前，布莱恩于2013年至2015年在印第安纳大学健康计划（英语:IU Health Plans）领导Medicare Advantage业务，该计划是印第安纳大学健康系统的一部分。2013年之前，Brian从2004年开始在Eli Lilly&Co.（一家全球制药公司）担任领导职位。Brian在Stanford University&8217；s Graduate School of Business获得工商管理硕士学位，在Wabash College获得经济学学士学位。
- Brian Clem has served as President of Oak Street Health since 2019 having joined the company in 2015 as a Divisional Vice President. Prior to joining Oak Street Health, Brian led the Medicare Advantage business from 2013 until 2015 at IU Health Plans, which is part of the Indiana University Health system. Prior to 2013 Brian served in leadership roles at Eli Lilly & Co., a global pharmaceutical company, beginning in 2004. Brian received an M.B.A. from Stanford University’s Graduate School of Business and a B.A. in Economics from Wabash College.
- Robert Guenthner
Robert Guenthner自2018年以来一直担任我们的首席法律官。在Oak Street Health任职之前，Guenthner先生于2014年至2017年担任National Surgical医疗保健的高级副总裁兼首席法律官，这是一家外科设施运营商，于2017年与公开交易的SurgeryPartners，Inc.合并。2014年之前，Guenthner先生从2005年开始担任跨国律师事务所Dentons及其前身公司的合伙人。Guenthner先生拥有圣路易斯华盛顿大学的法学博士和工商管理硕士学位以及代顿大学的金融和营销学士学位。
Robert Guenthner has served as our Chief Legal Officer since 2018. Prior to his role at Oak Street Health, Mr. Guenthner was the Senior Vice President and Chief Legal Officer from 2014 until 2017 at National Surgical Healthcare, an operator of surgical facilities that merged with the publicly traded Surgery Partners, Inc. in 2017. Prior to 2014 Mr. Guenthner was a partner at Dentons, a multi-national law firm and its predecessor firms, beginning in 2005. Mr. Guenthner received a J.D. and M.B.A. from Washington University in St. Louis and a B.S. in Finance and Marketing from the University of Dayton.- Robert Guenthner自2018年以来一直担任我们的首席法律官。在Oak Street Health任职之前，Guenthner先生于2014年至2017年担任National Surgical医疗保健的高级副总裁兼首席法律官，这是一家外科设施运营商，于2017年与公开交易的SurgeryPartners，Inc.合并。2014年之前，Guenthner先生从2005年开始担任跨国律师事务所Dentons及其前身公司的合伙人。Guenthner先生拥有圣路易斯华盛顿大学的法学博士和工商管理硕士学位以及代顿大学的金融和营销学士学位。
- Robert Guenthner has served as our Chief Legal Officer since 2018. Prior to his role at Oak Street Health, Mr. Guenthner was the Senior Vice President and Chief Legal Officer from 2014 until 2017 at National Surgical Healthcare, an operator of surgical facilities that merged with the publicly traded Surgery Partners, Inc. in 2017. Prior to 2014 Mr. Guenthner was a partner at Dentons, a multi-national law firm and its predecessor firms, beginning in 2005. Mr. Guenthner received a J.D. and M.B.A. from Washington University in St. Louis and a B.S. in Finance and Marketing from the University of Dayton.